Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y
ZacksDanaher’s (DHR) second-quarter earnings and revenues surpass estimates. However, the company’s performance reflects a decrease in core sales in the Biotechnology segment.
Danaher’s (DHR) second-quarter earnings and revenues surpass estimates. However, the company’s performance reflects a decrease in core sales in the Biotechnology segment.